γ-氨基丁酸治疗对哮喘患儿血浆P物质和降钙素基因相关肽含量的影响

徐传伟; 郭山春; 郑振文; 王庆元

doi:10.7499/j.issn.1008-8830.2013.02.007

PDF(914 KB)

中国当代儿科杂志 ›› 2013, Vol. 15 ›› Issue (2) : 102-104. DOI: 10.7499/j.issn.1008-8830.2013.02.007

论著·临床研究

γ-氨基丁酸治疗对哮喘患儿血浆P物质和降钙素基因相关肽含量的影响

徐传伟，郭山春，郑振文，王庆元

作者信息 +

Effect of gamma-aminobutyric acid treatment on plasma substance P and calcitonin gene-related peptide levels in children with asthma

XU Chuan-Wei, GUO Shan-Chun, ZHENG Zhen-Wen, WANG Qing-Yuan

Author information +

文章历史 +

摘要

目的：探讨γ-氨基丁酸（GABA）治疗前后哮喘患儿血浆P物质（SP）和降钙素基因相关肽(CGRP)含量的变化。方法：75例哮喘患儿随机分为GABA治疗组（36例）和对照组（39例），两组患儿均给予哮喘常规治疗。治疗组在常规治疗的基础上给予GABA口服 (每日25~30 mg/kg）。采用酶联免疫吸附法（ELISA）测定患儿治疗前、缓解后血浆SP、CGRP的含量。结果：两组患儿治疗前血浆SP、CGRP含量差异无统计学意义（P＞0.05）；哮喘缓解后治疗组血浆SP、CGRP含量分别为57±15 pg/mL、23±10 pg/mL，显著低于对照组（分别为127±12 pg/mL、 42±8 pg/mL），差异有统计学意义（P<0.01）。两组哮喘缓解后血浆SP、CGRP含量均较治疗前明显下降，差异有统计学意义（P<0.01）。哮喘患儿血浆SP与CGRP含量呈显著正相关（r=0.792，P<0.01）。结论：GABA可抑制小儿哮喘急性发作期血浆SP、CGRP的释放。

Abstract

OBJECTIVE: To study the changes in plasma substance P (SP) and calcitonin gene-related peptide (CGRP) levels in children with acute asthma before and after gamma-aminobutyricacid (GABA) treatment. METHODS: Seventy-five children with asthma were randomly assigned to GABA treatment (n=36) and control groups (n=39). Both groups were given conventional treatment for asthma. Besides the conventional treatment, the treatment group was administered with oral GABA (25-30 mg/kg?d). Plasma content of SP and CGRP was measured using ELISA before treatment and after remission. RESULTS: There were no significant differences in plasma content of SP and CGRP between the GABA treatment and control groups (P＞0.05) before treatment. Plasma content of SP and CGRP in the GABA treatment group was significantly lower than the control group (SP: 57±15 pg/mL vs 127±12 pg/mL; CGRP: 23±10 pg/mL vs 42±8 pg/mL) after remission (P<0.01). Plasma content of SP and CGRP after remission was significantly lower than before treatment (P<0.01) in both groups. There was a significantly positive correlation between plasma SP and CGRP content in asthmatic children (r=0.792, P<0.01). CONCLUSIONS: GABA can significantly decrease plasma levels of SP and CGRP in children suffering from acute asthma.

导出引用

徐传伟，郭山春，郑振文，王庆元. γ-氨基丁酸治疗对哮喘患儿血浆P物质和降钙素基因相关肽含量的影响[J]. 中国当代儿科杂志. 2013, 15(2): 102-104 https://doi.org/10.7499/j.issn.1008-8830.2013.02.007

XU Chuan-Wei, GUO Shan-Chun, ZHENG Zhen-Wen, WANG Qing-Yuan. Effect of gamma-aminobutyric acid treatment on plasma substance P and calcitonin gene-related peptide levels in children with asthma[J]. Chinese Journal of Contemporary Pediatrics. 2013, 15(2): 102-104 https://doi.org/10.7499/j.issn.1008-8830.2013.02.007

参考文献

［1］徐传伟, 夏应和, 郑振文, 张向前. γ氨基丁酸控制哮喘急性发作临床疗效观察［J］.滨州医学院学报,1999,22(2):181.

［2］魏兵, 王栾升.哮喘患儿血浆P物质、降钙素基因相关肽的测定及意义［J］.中国实用儿科杂志，1998,13（4）：223-224.

［3］中华医学会儿科学分会呼吸学组, 《中华儿科杂志》编辑委员会. 儿童支气管哮喘诊断与防治指南［J］. 中华儿科杂志,2008,46(10):745-753.

［4］尚云晓, 韩晓华, 程云威, 赵淑琴, 魏克伦. P物质与哮喘的关系(英文)［J］.中国当代儿科杂志,2003,5（2）: 185-188.

［5］叶丽红, 尚云晓. 哮喘患儿支气管诱导痰液中P物质含量变化的临床研究［J］.小儿急救医学,2004,11(1):33-35.

［6］俞茹云, 王彤, 殷凯生, 刘扣英, 陈俊娣. 支气管哮喘大鼠肺内非肾上腺能非胆碱能神经分布及其神经肽含量的相关性研究［J］.国际呼吸杂志,2008,28(12): 717-719.

［7］Xiang YY, Wang S, Liu M, Hirota JA, Li J, Ju W, et al. A GABAergic system in airway epithelium is essential for mucus overproduction in asthma［J］. Nat Med, 2007, 13(7): 862-867.

［8］Mizuta K, Xu D, Pan Y, Comas G, Sonett JR, Zhang Y, et al. GABAA receptors are expressed and facilitate relaxation in airway smooth muscle［J］. Am J Physion Lung Cell Mol Physiol, 2008, 294(6): L1206-L1216,

［9］Reyes-García MG, Hernández-Hernández F, Hernández-Téllez B, García-Tamayo F. GABA (A) receptor subunits RNA expression in mice peritoneal macrophages modulate their IL-6/IL-12 production［J］. J Neuroimmunol, 2007, 188(1): 64-68.

［10］Lu WY. The potential use of GABAergic drugs in the treatment of asthma［J］. Future Med Chem, 2011, 3(2): 145-147.

［11］孙月雯, 祝晋芳, 冯源. γ-氨基丁酸与哮喘的关系［J］.中国医药指南, 2010, 8(3): 40-42.

［12］Ray NJ, Jones AJ, Keen P. GABAB receptors modulation of the release of substance P from capsaicin-sensitive neurones in the rat rachea in vitro［J］. Br J Pharmacol, 1991, 102(4): 801-804.

［13］Mizuta K, Osawa Y, Mizuta F, Xu D, Emala CW. Functional Expression of GABAB Receptors in Airway Epithelium［J］. Am J Respir Cell Mol Biol, 2008, 39(3): 296-304.

［14］Osawa Y, Xu D, Sternberg D, Sonett JR, D′Armiento J, Panettieri RA, et al. Functional expression of the GABAB receptor in human airway smooth muscle［J］. Am J Physiol Lung Cell Mol Physiol, 2006, 291(5): L923-L931.